Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · powder, vial

Epic Peptides Lab · USA

Document number: PL-SDS-100
Revision: 1.0 · 2026-10-03

L-Carnitine

powder, vial

1Identification

Product Identifier

L-Carnitine

Document Number

PL-SDS-100

Catalogue Items Covered

Id
2240
Name
L-Carnitine 500mg
Sku
PL-LCARNITINE-500MG-VIAL

Recommended Use

Laboratory research use by trained personnel.

Restrictions On Use

Not for human or veterinary use.

Supplier / Distributor

Epic Peptides Lab, USA

Telephone

+1 (787) 468-5291

info@epicpeptideslab.com

2Hazard(s) identification

Classification: Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements: No data available.
Signal Word: No data available.
Other Hazards: No data available.

3Composition / information on ingredients

Description

Crystalline or amorphous powder in a sealed glass vial.

Composition

Name
L-Carnitine
Full
Levocarnitine (inner salt); small molecule, not a peptide
Cas
541-15-1
Formula
C7H15NO3
Conc
≥ 95% (dry basis, as supplied)
Qty
500 mg per vial

4First-aid measures

First Aid Measures

Inhalation: Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.

Most Important Symptoms And Effects

No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

Likely Routes Of Exposure

Inhalation of dust, skin and eye contact during weighing; ingestion through contaminated hands.

5Fire-fighting measures

Fire Fighting Information: Combustible organic solid; finely divided powder may form dust clouds.

6Accidental release measures

Spill And Clean Up Procedures: Avoid dust formation. Sweep or wipe up (dampened), place in a sealed container for disposal and clean the area with water.

7Handling and storage

Safe Handling: Avoid generating or inhaling dust; weigh inside a ventilated enclosure. Hygroscopic materials should be weighed quickly and the vial resealed. Wash hands after handling.
Safe Storage: Store sealed, cool and dry, protected from light. See Section 9 for the storage temperature.
Storage Temperature: Sealed, cool and dry (2–8 °C recommended), protected from light and moisture
Incompatible Materials: Strong oxidizing agents (Spectrum, ChemicalBook)

8Exposure controls / personal protection

Occupational Exposure Limits: No data available.
Exposure Controls And PPE: No data available.

9Physical and chemical properties

Physical State

Solid

Appearance

White crystalline powder (hygroscopic)

Properties

Odor: No information available
Ph: Not applicable (solid); aqueous solutions typically pH 4–7
Melting: 197-212 °C (Spectrum; Sigma lit.; ChemicalBook)
Boiling: No information available (287.5 °C rough estimate, ChemicalBook)
Flash: Not applicable (non-flammable solid); combustible organic material
Vapour: Negligible (solid)
Density: No data available (bulk density of lyophilized cake is low)
Solubility: Soluble in water, ca. 100 g/L at 20 °C (ChemicalBook); insoluble in acetone, benzene, ether (Spectrum)
Logp: No data available
Decomp: No data available; peptides decompose above about 200 °C
Other: Inner salt (zwitterion), MW 161.20; Sigma storage class 11 (combustible solids); flash point not applicable; TCI: store under inert gas, hygroscopic

10Stability and reactivity

Stability And Reactivity

Reactivity: Stable under recommended storage conditions
Incompatible: Strong oxidizing agents (Spectrum, ChemicalBook)
Decomposition: Carbon monoxide, carbon dioxide, nitrogen oxides (NOx) (Spectrum, ChemicalBook)
Conditions To Avoid: Heat, dust formation, incompatible materials (Spectrum); moisture - hygroscopic (ChemicalBook, TCI)

Conditions To Avoid

Heat, dust formation, incompatible materials (Spectrum); moisture - hygroscopic (ChemicalBook, TCI)

Incompatible Materials

No data available.

11Toxicological information

Toxicological Information: Acute toxicity, oral
LD50 oral, rat: > 5000 mg/kg; LD50 oral, rabbit: > 5000 mg/kg (ChemicalBook/Sigma-type); LD50 oral, mouse: 19.2 g/kg (Spectrum)

Acute toxicity, dermal
No information available

Acute toxicity, inhalation
No information available

Skin corrosion/irritation
Causes skin irritation (Spectrum, Cat. 2); no data / not classified (Sigma-type)

Serious eye damage/irritation
Causes eye irritation (Spectrum, Cat. 2B); no data / not classified (Sigma-type)

Respiratory or skin sensitisation
No information available

Germ cell mutagenicity
No information available

Carcinogenicity
Not considered carcinogenic (Spectrum); no IARC-identified carcinogen at >=0.1% (ChemicalBook); not listed by NTP, OSHA, Prop 65

Reproductive toxicity
No data available

STOT, single exposure
Irritating to respiratory system (Spectrum, Cat. 3); not classified (Sigma-type)

STOT, repeated exposure
No data available

Aspiration hazard
No data available
Routes Of Exposure: Inhalation of dust, skin and eye contact during weighing; ingestion through contaminated hands.
Symptoms: No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information: No ecotoxicity, persistence, bioaccumulation or mobility data available (Spectrum, ChemicalBook). Expected readily biodegradable.

13Disposal considerations

Disposal Guidance: No data available.

14Transport information

Transport Classification

Note: Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information

Tsca: Not listed (Spectrum; ChemicalBook) - verify against current inventory
Carcinogen Listings: Not listed (IARC, NTP, OSHA, California Prop 65)
Dea: Not a controlled substance
Other: FDA: present, not regulated under 21 CFR (Spectrum); EINECS and China IECSC listed; not Korea KECL. WADA remark: not prohibited (but intravenous infusions >100 mL per 12 h are a prohibited method M2).

Carcinogen Listings

No data available.

16Other information

Revision: October 3, 2026
Sources Consulted: Spectrum Chemical

ChemicalBook

Sigma-Aldrich

TCI
Confidence: medium
Additional Information: Spectrum classifies the substance as a skin, eye and respiratory irritant; Sigma-Aldrich does not (oral LD50 rat > 5,000 mg/kg). Sigma-Aldrich is followed.

Back to SDS list